Oaktree Acquisition III Life Sciences EBITDA Margin 2025-2024 | OACC

Oaktree Acquisition III Life Sciences ebitda margin from 2025 to 2024. Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.
Related Stocks
Company NameMarket
Cap
Flowco Holdings (FLOC)$1.8B
Range Capital Acquisition (RANG)$141M
Tavia Acquisition (TAVI)$140M
Aduro Clean Technologies (ADUR)$126M
YSX Tech (YSXT)$101M
CO2 Energy Transition (NOEM)$96M
Leishen Energy Holding (LSE)$91M
YHN Acquisition I (YHNA)$82M
Youxin Technology (YAAS)$43M
New Century Logistics (BVI) (NCEW)$37M
Sky Quarry (SKYQ)$16M
PicoCELA (PCLA)$12M
Hong Kong Pharma Digital Technology Holdings (HKPD)$10M